Όλο το DSpace

Πλοήγηση ανά Θέμα "dabigatran etexilate"

Αποτελέσματα 1-5 από 5

    • Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement 

      Liampas I., Chlinos A., Siokas V., Brotis A., Dardiotis E. (2019)
      Randomized controlled trials (RCTs) are the cornerstone of evidence based medicine. Ιt is crucial that RCTs have transparent reporting to facilitate their interpretation. The purpose of the present study is the evaluation ...

    • Dabigatran: The anticoagulant we have long expected? 

      Tagarakis, G. I.; Karangelis, D.; Daskalopoulos, M. E.; Tsilimingas, N. B. (2010)
      Many researchers have until now united their efforts in the endeavor to discover new anticoagulants, which would be simpler to use and safer to administer, so that patients would avoid both thromboembolic events as well ...

    • Embolic Stroke of Undetermined Source: JACC Review Topic of the Week 

      Ntaios G. (2020)
      The term embolic stroke of undetermined source (ESUS) was introduced in 2014 to describe patients with a nonlacunar ischemic stroke and no convincing etiology. The terms ESUS and cryptogenic stroke are not synonyms, as the ...

    • Perioperative Management of Patients with Atrial Fibrillation Receiving a Direct Oral Anticoagulant 

      Douketis J.D., Spyropoulos A.C., Duncan J., Carrier M., Le Gal G., Tafur A.J., Vanassche T., Verhamme P., Shivakumar S., Gross P.L., Lee A.Y.Y., Yeo E., Solymoss S., Kassis J., Le Templier G., Kowalski S., Blostein M., Shah V., Mackay E., Wu C., Clark N.P., Bates S.M., Spencer F.A., Arnaoutoglou E., Coppens M., Arnold D.M., Caprini J.A., Li N., Moffat K.A., Syed S., Schulman S. (2019)
      Importance: Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and request elective surgery or procedure present a common clinical situation yet perioperative management is uncertain. Objective: ...

    • Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion 

      Diener H.C., Bernstein R., Butcher K., Campbell B., Cloud G., Davalos A., Davis S., Ferro J.M., Grond M., Krieger D., Ntaios G., Slowik A., Touzé E. (2017)
      Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed ...